AFT Pharmaceuticals $3.400
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 5:54am | ||||
AFT PHARMACEUTICALS LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $377,548,736 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $4.13 |
52w Low $2.70 |
P/E 18.18 |
EPS 0.12 |
FY2023 App2
AFP released this announcement to the ASX on 22 May 2023, 8:01. The announcement is marked as price sensitive, and is 1 page(s) in length and 166.71kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| FY2023 App2 | 22 May 2023, 8:01 |
| to announce full year results on Monday May 22 2023 | 4 May 2023, 7:32 |
| US FDA sets PDUFA date for Maxigesic IV | 1 May 2023, 7:34 |
| AFT submits Maxigesic IV packaging data to the US FDA | 18 April 2023, 7:31 |
If you were already registered, log in here.
If you were already registered, log in here.